The Journal of Organic Chemistry
Article
THF (20 mL) was cooled down to 0 °C. Sodium hydride (60%
dispersion in mineral oil, 160 mg, 4.00 mmol) was added, and the
solution was stirred for 15 min at 0 °C and then 15 min at rt. Then, t-
butyldimethylsilyl chloride (633 mg, 4.20 mmol) was added, and the
reaction mixture was stirred at rt for 18 h. Saturated aqueous
ammonium chloride (20 mL) and water (20 mL) were then added.
The aqueous phase was extracted with CH2Cl2 (3 × 50 mL); the
organic extracts were combined, dried over anhydrous MgSO4, filtered
and concentrated under reduced pressure. The crude product was
purified by flash chromatography on silica gel using ethyl acetate and
hexanes (30:70) as eluent to give 7-(benzyloxy)-2-(tert-butyldime-
thylsilyloxy)-3-hydroxy-7-azaspiro[4.5]decan-6-one (29) as colorless
2,3,3-Trimethyl-6-oxopiperidin-1-yl trifluoromethanesulfo-
nate (13i). To a solution of hydroxamic acid 3i (0.200 g, 1.27
mmol) in dichloromethane (6 mL) at 0 °C was added triethylamine
(0.26 mL, 1.9 mmol) and triflic anhydride (0.26 mL, 1.52 mmol).
After being stirred 5 min at 0 °C, the solvent was removed under
reduced pressure, and the residue was purified by flash chromatog-
raphy on silica gel using ethyl acetate and hexanes (15:85) as eluent to
give 13i as colorless oil (0.258 g, 70%): 1H NMR (300 MHz, CDCl3)
δ (ppm) 3.72 (q, 1H, J = 6.4 Hz), 2.66 (ddd, 1H, J = 17.4, 11.0, 7.0
Hz), 2.56 (ddd, 1H, J = 17.4, 6.7, 3.8 Hz), 1.84 (ddd, 1H, J = 14.1,
11.0, 6.7 Hz), 1.57−1.49 (m, 1H), 1.30 (d, 3H, J = 6.4 Hz), 1.27 (s,
3H), 1.06 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 169.4 (s),
118.4 (q, J = 322 Hz), 70.8 (d), 36.1 (s), 30.5 (t), 30.1 (t), 25.7 (q),
13.6 (q); IR (CHCl3) ν (cm−1) 2978, 1641, 1463, 1291, 1168, 1029.
LRMS and HRMS could not be obtained because of the thermal
instability of the molecule.
2,3,3-Trimethyl-6-oxopiperidin-1-yl 4-methylbenzenesulfo-
nate (32). To a solution of hydroxamic acid 3i (0.151 g, 0.960 mmol)
in dichloromethane (7 mL) was added triethylamine (0.16 mL, 1.2
mmol), DMAP (35 mg, 0.29 mmol) and tosyl chloride (0.202 g, 1.06
mmol). After being stirred 15 min at rt, water (25 mL) and a 1 M
aqueous HCl solution (25 mL) were added. The aqueous phase was
extracted with dichloromethane (3 × 50 mL); the organic extracts
were combined, dried over anhydrous magnesium sulfate, filtered and
concentrated under reduced pressure. The crude product was purified
by flash chromatography on silica gel using ethyl acetate and hexanes
(25:75) as eluent to give 2,3,3-trimethyl-6-oxopiperidin-1-yl 4-
methylbenzenesulfonate (32) as colorless oil (0.156 g, 52%): 1H
NMR (300 MHz, CDCl3) δ (ppm) 7.88 (d, 2H, J = 8.3 Hz), 7.32 (d,
2H, J = 8.3 Hz), 3.79 (q, 1H, J = 6.4 Hz), 2.44 (s, 3H), 2.29−2.24 (m,
2H), 1.77 (ddd, 1H, J = 13.8, 9.1, 9.1 Hz), 1.38 (dt, 1H, J = 13.8, 4.8
Hz), 1.25 (d, 3H, J = 6.4 Hz), 1.25 (s, 3H), 1.00 (s, 3H); 13C NMR
(75.5 MHz, CDCl3) δ (ppm) 168.4 (s), 145.9 (s), 131.4 (s), 129.5
(d), 129.3 (d), 69.3 (d), 35.2 (s), 30.2 (t), 29.7 (t), 26.1 (q), 25.9 (q),
21.8 (q), 13.9 (q); IR (CHCl3) ν (cm−1) 3047, 2978, 2943, 2874,
1710, 1600, 1463, 1372, 1175, 1090; LRMS (m/z, relative intensity)
334 (MNa+, 100); HRMS calculated for C15H21NO4SNa 334.1084,
found 334.1088.
1
oil (1.30 g, 84%): H NMR (300 MHz, CDCl3) δ (ppm) 7.44−7.40
(m, 2H), 7.38−7.35 (m, 3H), 4.96−4.89 (AB quartet, 2H), 4.40 (ddd,
1H, J = 7.5, 7.5, 4.2 Hz), 4.13−4.09 (m, 1H), 3.42−3.29 (m, 2H), 2.54
(br s, 1H), 2.32 (ddd, 2H, J = 13.8, 7.5, 5.4 Hz), 1.85−1.71 (m, 4H),
1.67 (dd, 1H, J = 13.8, 3.3 Hz), 1.56 (dd, 1H, J = 13.8, 7.6 Hz), 0.91
(s, 9H,) 0.11 (s, 3H), 0.10 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ
(ppm) 173.7 (s), 135.3 (s), 129.6 (d), 128.7 (d), 128.4 (d), 75.3 (t),
75.0 (d), 73.9 (d), 50.9 (t), 47.7 (s), 43.6 (t), 42.4 (t), 36.6 (t), 25.8
(q), 20.6 (t), 18.0 (s), −4.6 (q), −5.0 (q); IR (CHCl3) ν (cm−1) 3050,
2956, 1641, 1256, 1100; LRMS (m/z, relative intensity) 406 (MH+,
100), 428 (MNa+, 50); HRMS calculated for C22H35NO4SiH+
406.2408, found 406.2413.
7-(Benzyloxy)-2-(tert-butyldimethylsilyloxy)-3-hydroxy-7-azaspiro-
[4.5]decan-6-one (29) (1.30 g, 3.21 mmol) was dissolved in CH2Cl2
(16 mL) and cooled down to 0 °C. Triethylamine (1.12 mL, 8.01
mmol), acetic anhydride (0.61 mL, 6.4 mmol), and a catalytic amount
of DMAP were then successively added, and the reaction mixture was
stirred for 2 h while being left to slowly warm up to rt. Aqueous
saturated NH4Cl (15 mL) and water (15 mL) were then added, and
the mixture was extracted with CH2Cl2 (3 × 50 mL). The organic
extracts were combined, washed with aqueous saturated K2CO3 (50
mL), dried over anhydrous MgSO4, filtered and concentrated under
reduced pressure to yield 7-(benzyloxy)-3-(tert-butyldimethylsilyloxy)-
6-oxo-7-azaspiro[4.5]decan-2-yl acetate (30) (1.44 g, 100%) as
1
colorless oil: H NMR (300 MHz, CDCl3) δ (ppm) 7.44−7.40 (m,
2H), 7.38−7.35 (m, 3H), 5.18 (ddd, 1H, J = 6.0, 6.0, 4.1 Hz), 4.93 (s,
2H), 4.45 (ddd, 1H, J = 6.0, 6.0, 4.1 Hz), 3.42−3.30 (m, 2H), 2.46
(dd, 1H, J = 13.6, 6.0 Hz), 2.36 (dd, 1H, J = 13.3, 6.0 Hz), 2.05 (s,
3H), 1.85−1.74 (m, 4H), 1.70 (dd, 1H, J = 13.6, 6.0 Hz), 1.59 (dd,
1H, J = 13.3, 6.0 Hz), 0.87 (s, 9H), 0.06 (s, 3H), 0.04 (s, 3H); 13C
NMR (75.5 MHz, CDCl3) δ (ppm) 173.2 (s), 170.1 (s), 135.2 (s),
129.5 (d), 128.6 (d), 128.3 (d), 76.1 (d), 75.2 (t), 73.0 (d), 50.8 (t),
46.7 (s), 43.7 (t), 40.0 (t), 36.4 (t), 25.7 (q), 21.1 (q), 20.5 (t), 18.0
(s), −5.0 (q), −5.1 (q); IR (CHCl3) ν (cm−1) 3040, 2953, 1726, 1657,
1262, 1125; LRMS (m/z, relative intensity) 448 (MH+, 100), 470
(MNa+, 85); HRMS calculated for C24H37NO5SiH+ 448.2514, found
448.2518.
2-Methyl-6-oxopiperidin-1-yl methanesulfonate (2o). Trie-
thylamine (0.49 mL, 3.5 mmol) and 4-dimethylaminopyridine (86 mg,
0.70 mmol) were added to a solution of hydroxamic acid 3o (300 mg,
2.32 mmol) in dichloromethane (12 mL). Mesyl chloride (0.22 mL,
2.8 mmol) was added, and the reaction mixture was stirred at rt for 15
min. The solvent was removed under reduced pressure, and the crude
product was purified by flash chromatography on silica gel using a
mixture of ethyl acetate and hexanes (50:50) as eluent to give
1
compound 2o as colorless oil (376 mg, 78%): H NMR (300 MHz,
CDCl3) δ (ppm) 4.17−4.04 (m, 1H), 3.29 (s, 3H), 2.56 (t, 2H, J = 6.6
Hz), 2.24−2.09 (m, 1H), 1.99−1.87 (m, 1H), 1.86−1.72 (m, 2H),
1.38 (d, 3H, J = 6.4 Hz); 13C NMR (75.5 MHz, CDCl3) δ (ppm)
169.0 (s), 60.2 (d), 39.1 (q), 33.7 (t), 31.2 (t), 18.4 (q), 18.0 (t); IR
(CHCl3) ν (cm−1) 2984, 2959, 2884, 1688, 1450, 1366, 1325, 1291,
1172, 968; LRMS (m/z, relative intensity) 230 (MNa+, 100), 208
(MH+, 1); HRMS calculated for C7H13NO4SNa 230.0458, found
230.0474; mp 52−54 °C.
7-(Benzyloxy)-3-(tert-butyldimethylsilyloxy)-6-oxo-7-azaspiro[4.5]-
decan-2-yl acetate (30) (956 mg, 2.13 mmol) was dissolved in ethanol
(21 mL). A catalytic amount of 5% palladium on activated carbon was
added, and the solution was degassed by bubbling argon for 10 min.
Argon was replaced by hydrogen, and the latter was bubbled through
the solution for several seconds. After being stirred for 1 h under
hydrogen, argon was bubbled through the solution for another 10 min.
The reaction mixture was then filtered on Celite while being washed
with EtOH. The solvent was removed under reduced pressure to yield
2-Oxo-3,3-dipropylazepan-1-yl methanesulfonate (2r). Trie-
thylamine (0.30 mL, 2.1 mmol) and 4-dimethylaminopyridine (51 mg,
0.42 mmol) were added to a solution of hydroxamic acid 3r (300 mg,
1.41 mmol) in dichloromethane (9 mL). Mesyl chloride (0.13 mL, 1.7
mmol) was added, and the reaction mixture was stirred at rt for 5 min.
The solvent was removed under reduced pressure, and the crude
product was purified by flash chromatography on silica gel using a
mixture of ethyl acetate and hexanes (10:90) as eluent to give
1
hydroxamic acid 3u as an oil (713 mg, 93%): H NMR (300 MHz,
CDCl3) δ (ppm) 5.17 (ddd, 1H, J = 6.3, 6.3, 4.0 Hz), 4.43 (ddd, 1H, J
= 5.6, 5.6, 4.0 Hz), 3.65−3.58 (m, 2H), 2.43 (dd, 1H, J = 13.6, 6.3
Hz), 2.33 (dd, 1H, J = 13.4, 5.6 Hz), 2.05 (s, 3H), 1.97−1.91 (m, 4H),
1.76 (dd, 1H, J = 13.6, 6.3 Hz), 1.64 (dd, 1H, J = 13.4, 5.6 Hz), 0.87
(s, 9H), 0.05 (s, 3H), 0.03 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ
(ppm) 170.9 (s), 170.2 (s), 76.1 (d), 72.9 (d), 49.8 (t), 45.2 (s), 43.5
(t), 39.9 (t), 36.3 (t), 25.7 (q), 21.1 (q), 19.9 (t), 18.0 (s), −5.1 (q),
−5.1 (q); IR (CHCl3) ν (cm−1) 3281 (br), 2978, 1729, 1610, 1256,
1046; LRMS (m/z, relative intensity) 380 (MNa+, 100); HRMS
calculated for C17H31NO5SiNa+ 380.1864, found 380.1866.
1
compound 2r as colorless oil (391 mg, 95%): H NMR (300 MHz,
CDCl3) δ (ppm) 3.95−3.91 (m, 2H), 3.13 (s, 3H), 1.93−1.80 (m,
2H), 1.78−1.45 (m, 8H), 1.27 (sext, 4H, J = 7.2 Hz), 0.92 (t, 6H, J =
7.2 Hz); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 177.1 (s), 56.0 (t),
47.7 (s), 39.3 (t), 37.7 (q), 32.1 (t), 26.6 (t), 22.3 (t), 17.0 (t), 14.6
(q); IR (neat) ν (cm−1) 2965, 2934, 2878, 1691, 1466, 1366, 1322,
1175, 1046, 962, 880; LRMS (m/z, relative intensity) 314 (MNa+,
11224
dx.doi.org/10.1021/jo3023507 | J. Org. Chem. 2012, 77, 11216−11226